Product
Blood Sample
Aliases
blood sample
15 clinical trials
28 indications
Indication
CancerIndication
Genetic PredispositionIndication
SarcopeniaIndication
Systemic Lupus ErythematosusIndication
Antiphospholipid SyndromeIndication
ThrombocytopeniaIndication
Implant ComplicationIndication
Contraceptive Device ComplicationsIndication
StrokeIndication
Cerebral InfarctionIndication
COVID-19Indication
HemostasisIndication
Congenital heart defectsIndication
Fibrous DysplasiaIndication
Albright's syndromeIndication
Adult ChildrenIndication
HypoparathyroidismIndication
HyperparathyroidismIndication
PseudohypoparathyroidismIndication
ColitisIndication
UlcerativeIndication
Systemic SclerosisIndication
SensitizationIndication
Allergic RhinitisIndication
respiratory diseaseIndication
Hyperviscosity SyndromeIndication
Waldenstrom MacroglobulinemiaIndication
Fuchs Endothelial Corneal DystrophyClinical trial
EXOME Analysis Position in the Strategy of Genetic Predisposition Factors Identification in Early-onset CancerStatus: Recruiting, Estimated PCD: 2026-10-07
Clinical trial
Observational Pilot Study in Patients Who Underwent Tracheostomy: Sarcopenia Assessment by Handgrip Strenght and BIA. Association to Malnutrion Risk, Nutritional Status, Gut Microbioma and Decannulation Time.Status: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
Systemic Lupus Erythematosus and Accelerated AgingStatus: Recruiting, Estimated PCD: 2025-09-01
Clinical trial
Domain 1 of β2-Glycoprotein 1 Autoantibodies and Thrombin Generation Capacity in Patients With Antiphospholipid AntibodiesStatus: Recruiting, Estimated PCD: 2027-03-13
Clinical trial
Thrombocytopenia Drug Immune Validation of New Biological Test DiagnosticStatus: Completed, Estimated PCD: 2021-03-15
Clinical trial
Prospective Multicenter Study of the Improvement of Symptoms After Removal of the Essure® Contraceptive ImplantStatus: Not yet recruiting, Estimated PCD: 2031-08-01
Clinical trial
D-dimer Prognostic Marker of Cerebral Infarction After Revascularization ProcedureStatus: Recruiting, Estimated PCD: 2023-09-01
Clinical trial
Thrombo Embolic Events in Hospitalized Patients With Covid-19 Serious Acute PneumopathyStatus: Recruiting, Estimated PCD: 2023-10-01
Clinical trial
Creation of a French South-Eastern Database and DNA-bank of Congenital Heart Disease to Explore the Genetic PathwaysStatus: Recruiting, Estimated PCD: 2028-01-01
Clinical trial
Autotaxin in Patients With GNAS/PTH AbnormalitiesStatus: Completed, Estimated PCD: 2023-01-11
Clinical trial
Detection of Herpesvirus DNA (CMV, EBV, HHV-6 and HSV) in Colonic Tissue: Impact on Ulcerative Colitis Flare-upStatus: Active (not recruiting), Estimated PCD: 2024-03-13
Clinical trial
Microparticles's Role in the Pathophysiology of Systemic Lupus Erythematosus and Systemic SclerosisStatus: Completed, Estimated PCD: 2021-09-14
Clinical trial
Hypersensitivity Pneumonitis of Domestic Origin: Investigation of the Microorganisms Involved and Improvement of Serological Diagnosis.Status: Not yet recruiting, Estimated PCD: 2026-03-01
Clinical trial
Clinical Study of the Hyperviscosity Syndrome in Waldenström MacroglobulinemiaStatus: Recruiting, Estimated PCD: 2024-05-01
Clinical trial
Analysis of the Genotype/Phenotype Relationship in the Fuchs' Corneal Endothelial Dystrophy in France. The French Fuchs' Follow-up Study, F3SStatus: Completed, Estimated PCD: 2020-11-10